HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul Edison Selected Research

Paul Edison Research Topics

Disease

33Alzheimer Disease (Alzheimer's Disease)
01/2022 - 07/2006
14Cognitive Dysfunction
01/2022 - 01/2013
12Neuroinflammatory Diseases
01/2021 - 05/2015
7Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 08/2011
6Dementia (Dementias)
01/2022 - 08/2011
6Disease Progression
01/2019 - 05/2015
5Inflammation (Inflammations)
01/2020 - 02/2014
3Parkinson Disease (Parkinson's Disease)
12/2015 - 05/2013
2Atrophy
01/2022 - 07/2006
2Insulin Resistance
01/2021 - 01/2016
2Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2019
2Tauopathies
01/2019 - 01/2016
1Normal Pressure Hydrocephalus
08/2021
1Genetic Risk Score
01/2021
1Prodromal Symptoms
01/2021
1Multiple Sclerosis
10/2019
1Obesity
01/2019
1Encephalitis (Encephalitis, Rasmussen)
07/2017
1Traumatic Brain Injuries (Traumatic Brain Injury)
03/2016
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2016
1Corticobasal Degeneration
01/2016
1Chronic Traumatic Encephalopathy
01/2016
1Frontotemporal Dementia (Semantic Dementia)
01/2016
1Pathologic Processes
12/2015
1Hyperinsulinism (Hyperinsulinemia)
12/2015
1Amyloid Plaque
11/2013
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
03/2012
1Prion Diseases (Transmissible Spongiform Encephalopathies)
03/2012
1Huntington Disease (Huntington's Disease)
05/2007

Drug/Important Bio-Agent (IBA)

28Amyloid (Amyloid Fibrils)IBA
01/2022 - 07/2006
92- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
10/2019 - 07/2006
7Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2015
7Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2013
4Proteins (Proteins, Gene)FDA Link
01/2018 - 05/2015
3Insulin (Novolin)FDA Link
01/2021 - 02/2014
3LiraglutideFDA Link
01/2020 - 12/2015
3Glucagon-Like Peptide 1 (GLP 1)IBA
01/2020 - 12/2015
3PK 11195 (PK11195)IBA
06/2015 - 05/2007
2Amyloid beta-PeptidesIBA
01/2022 - 01/2020
2tau Proteins (tau Protein)IBA
01/2019 - 01/2016
2Neuroprotective AgentsIBA
01/2019 - 01/2018
2Apolipoprotein E4IBA
01/2018 - 05/2015
14- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA
10/2021
1ApolipoproteinsIBA
01/2021
1LipidsIBA
01/2021
1(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA
01/2018
1CytokinesIBA
01/2017
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2017
1THK5351IBA
01/2016
17- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
01/2016
1LigandsIBA
01/2016
1lixisenatideIBA
12/2015
1Insulin ReceptorIBA
12/2015
1Exenatide (Byetta)FDA Link
12/2015
1(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA
09/2015
1isoquinolineIBA
06/2015
1Pharmaceutical PreparationsIBA
11/2012
1Presenilin-1IBA
01/2011

Therapy/Procedure

1Activities of Daily Living (ADL)
01/2019
1Therapeutics
11/2012